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How can stenosis of one renal
artery cause failure of
two kidneys?
To the Editor: The suggestion that treating renal artery
stenosis of one kidney can prevent progressive renal fail-
ure of both kidneys is not new, but it remains biologically
implausible [1]. Who has ever seen a patient with uni-
lateral fibromuscular dysplasia and a serum creatinine of
400 lmol/L?
Korsakas et al [1] describe a cohort of 28 patients
with advanced renal failure and atheromatous renal
artery stenosis (ARAS). In the 17 patients with unilateral
ARAS, what was causing the progressive renal impair-
ment in the contralateral kidney, and how could revas-
cularization of the other kidney arrest this process? The
authors make two suggestions. Improved blood pressure
(BP) control after intervention could slow the progres-
sion of nephropathy, but there were no major changes
in BP in the study. Alternatively, the patients may have
had a “diffuse renal disease” and superimposed ARAS.
Clearly, this must have been the case in the unilateral
group, and if we have to postulate the existence of another
diffuse disease to explain the problem in one kidney, why
would it not be the culprit in the other? This diffuse dis-
ease is increasingly well recognized, and should perhaps
be called atherosclerotic nephropathy (AN) [2].
The hypothesis that best explains the results in this and
other studies in ARAS is that most hypertensive arteri-
opaths with chronic progressive renal failure have AN,
and quite a lot of them (because of the common predispo-
sitions) coincidentally have ARAS. AN causes progres-
sive nephron loss at a fairly uniform rate. ARAS can cause
a rise in serum creatinine because of underperfusion of
viable nephrons, reversible after revascularization. The
superimposition of these two conditions fits nicely with
the evident, but short-lived, improvement after revascu-
larization seen in this paper.
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Icodextrin-induced sterile
peritonitis: Neutrophil
activation and peritoneal
injury
To the Editor: I read with great interest the article by
Toure´ et al on comparison between icodextrin-induced
peritonitis (IP) and bacterial peritonitis (BP) [1]. They ex-
amined surface expression of several neutrophils recep-
tors and found that activated peritoneal-infiltrating neu-
trophils were distinct from resting circulating neutrophils
because of phenotypic changes. Their results showed a
smaller inflow of activated neutrophils in IP that in BP.
However, in IP, few neutrophils are identified, but
marked cellular infiltration of the connective tissue by
lymphocytes, eosinophils, and mast cells was identified
in the first peritoneal biopsy from a patient with a
typical symptomatology [2]. Immunoperoxidase stain-
ing demonstrated that the infiltrating cells were mostly
macrophages (CD68) and T lymphocytes (CD3) [2].
Mechanisms of activation of these cell populations should
thus be evaluated and compared too in IP and in BP in
further studies.
Toure´ et al suggest too that peritoneal injury was less
severe in IP than in BP. This affirmation is based on com-
parison between solute clearances and CA125 concen-
trations in IP and BP [1]. Despite this report, several
lines of evidence suggest that IP is not a benign event:
several manifestations of acute peritoneal inflammation,
including mesothelial inflammation and desquamation,
presence of fibrin clusters on the peritoneal surface, and
edema, varying degrees of peritoneal inflammation char-
acterized by venulitis, together with marked cellular
infiltration, were recently identified [2, 3]. These data
confirm the hypothesis that peritoneal inflammation of
the icodextrin-associated peritonitis is not so benign.
Further investigations are needed to determine the im-
pact of IP inflammatory lesions on the peritoneal mem-
brane longevity.
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